| Metric | შპს ნიუ ფარმა | შპს ივერმედი |
|---|---|---|
| Growth | ||
| Revenue | ₾14.6m₾21.9m | ₾45.9m₾47.1m |
| Revenue growth | -33.2% | -2.5% |
| Profitability | ||
| EBITDA | -₾27k₾3.5m | -₾1.1m₾3.1m |
| EBITDA margin | -0.2%15.8% | -2.4%6.6% |
| Net profit | -₾1.2m₾2.1m | -₾993k₾4.4m |
| Net margin | -8.4%9.7% | -2.2%9.3% |
| Balance sheet | ||
| Total assets | ₾9.7m₾10.9m | ₾38.9m₾42.4m |
| Total equity | ₾3.4m₾5.9m | ₾30.8m₾35.6m |
| ROE | -35.4%36.1% | -3.2%12.3% |